ViroPharma | Evaluate

September 01, 2016

Therapy focus – Clinging to options in Friedreich’s ataxia

Upcoming events – Infinity and AbbVie await duvelisib data while Aurinia needs voclosporin to deliver

February 08, 2016

BioCryst hit with a HAE-maker

July 23, 2014

Sovaldi not the first to break the bank

May 29, 2014

BioCryst pushes positive HAE news and taps market once again

February 07, 2014

Shire depression failure sharpens focus on dealmaking

February 05, 2014

Event – Shire casts its net for bigger Vyvanse catch

January 08, 2014

Small cap biotechs reap rewards of the bull market in 2013

November 11, 2013

ViroPharma gets out while the going's good

October 02, 2013

US outperformance dominates small-cap drug stock gains

September 16, 2013

ViroPharma should seize the opportunity of a sale

Load More